Ahmed A. Al-Karmalawy, Mohamed E. Eissa, Nada A. Ashour, Tarek A. Yousef, Arwa Omar Al Khatib and Samia S. Hawas
RSC Adv., 2025,15, 36441-36471
Abstract
Medicinal chemistry perspective on anticancer drug design (2015–2025).
Shujauddin Ahmed, Akash P. Sakla, Kousar Jahan, Naziya Neshat, Mymoona Akhter, Shams Aaghaz and Ahmed Kamal
RSC Med. Chem., 2026, Advance Article
From themed collection:
Celebrating the 5th Anniversary of RSC Medicinal Chemistry
Abstract
Recent advances in medicine and drug development have significantly changed how cancer is treated.
Ekaterina A. Khmelevskaya, Natalia A. Danilkina, Sergey A. Silonov, Evgeny V. Tretyakov, Alexander F. Khlebnikov, Vladimir E. Melnikov, Anastasiia V. Nikitina, Andrey M. Rumyantsev, Mariya A. Kryukova and Irina A. Balova
Org. Biomol. Chem., 2026, Advance Article
Abstract
A click synthetic approach towards benzothiophene-fused enediyne hybrids was developed. The lead structure containing a Hoechst-type MGB ligand and a triazole linker with nanomolar cytotoxicity against HeLa cells was identified.
Ramesh Chaudhari, Vishva Patel and Ashutosh Kumar
Nanoscale Adv., 2024,6, 2270-2286
From themed collection:
Recent Review Articles
Abstract
Discover the groundbreaking potential of nanotech-based targeted delivery in breast cancer therapy. Our review showcases how this innovative precision medicine approach can revolutionise treatment and improve patient outcomes.
Mannat Jain, Isha M. Jadhav, Suyash Vinayak Dangat, Srinivasa Rao Singuru, Gautam Sethi, Eiji Yuba and Rajesh Kumar Gupta
Biomater. Sci., 2025,13, 3447-3497
From themed collection:
Biomaterials Science Open Access Spotlight
Abstract
(a) Two primary mechanisms for cross-presentation of internalized antigens: cytosolic and vacuolar pathways. (b) To enhance antigen presentation and generate T cell responses, glycans are multivalently presented on a range of nanocarrier systems.